Stryker Makes Big Investment In Spine Surgery With $1.4Bn K2M Acquisition
Executive Summary
The orthopedics giant will pay $27.50 per share for the Leesburg, Va., company, representing a 27% premium over K2M's average closing price over the last 90 days. The terms of the deal also call for K2M CEO to take over as president of Stryker's Spine business, displacing current president Bradley Paddock.
You may also be interested in...
Stryker Goes Shoulder To Shoulder With Wright Medical In $4Bn Takeover
Stryker is acquiring rival Wright Medical in a $4bn deal catapulting the company to a top position in the trauma and extremities market. The agreement, announced on 4 November, is Stryker’s biggest acquisition this year.
Stryker’s Mako Robot Continues To Bite Orthopedic Surgery Competition
The company said it expected Mako to continue to drive market share gains in hip and knee surgery. Stryker sold 51 Mako robotic orthopedic surgery systems in the third quarter, bringing the total installed base to 772.
2018 Earnings Spotlight: Stryker And Nuvasive Lead The Ortho Pack In 2018
Reported sales and earnings from the big publicly traded orthopedics device companies showed mostly slow growth in 2018, but NuVasive and Stryker reported high single-digit growth while, Smith & Nephew grew in the low single-digits, fueling reports that Smith & Nephew may try to buy NuVasive.